Bryan G. Helwig, Ph.D. - Lawyer in Chicago, IL

Bryan Helwig, Ph. D. McDonnell Boehnen is a partner at Hulbert & Berghoff LLP. Dr. Helwig has extensive experience in drafting and prosecuting patent applications in pharmaceuticals, biology, biochemistry, and life sciences. In addition to U.S. prosecutions, Dr. Helwig is well versed in prosecuting international applications. He advises on new and emerging drugs and biological protection. In addition, Dr. Helwig advises clients on freedom of operation, patent infringement, patent validity, litigation and litigation-related issues.

Prior to joining MBHB, Dr. Helwig led a laboratory for the U.S. Department of Defense. His research portfolio was tasked with the development of pharmaceutical and non-pharmaceutical therapies, as well as advances in molecular and physiological device technologies that support the survival of fighters in extreme environments. Integrative research has utilized a wide range of molecular biology, protein chemistry and high throughput techniques. Also, Doctor. Helwig has also served as a consultant to numerous Fortune 500 companies, advising on the scientific validity of classification claims and product development.

Dr. Helwig's postgraduate and doctoral studies focus on the transformation of stem cells into neurons and heart cells, heart failure, and changes in central nervous regulation of autonomic nervous function.